FBXW7 and neoplasm: We found that myeloid cell-specific FBXW7-deficient (Lysm+FBXW7f/f) C57BL/6 mice showed exacerbated tumor progression and had a higher proportion of M2-like TAMs in solid tumor tissues after the subcutaneous injection of Lewis lung carcinoma cells (LLCs).